Zydus seeks DCGI approval for using PegIFN in COVID-19 treatment
91.15% of patients treated with PegIFN were RT PCR negative by day 7 as compared to 78.90% on the standard of care (SOC) arm
Pegihep Peg Zydus Cadila Sharvil Patel Cadila Healthcare Ltd Pegylated Interferon Alpha Signal Transduction
Source: biospectrumindia.com